Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates

Jeffrey C. Kern, R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mark T. Cancilla, Rena Zhang, Anthony Palmieri, Prasanthi Geda, Peter Stivers, Andrew Beck(Beth Israel Deaconess Medical Center), Isabel Figueroa(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nick Knudsen(Ambrx (United States)), Jeffrey Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mangeng Cheng, Kristen Kwasnjuk, Anthony Manibusan(Ambrx (United States)), Daniela M. Tomazela(Merck & Co., Inc., Rahway, NJ, USA (United States)), Juhi Firdos(Ambrx (United States)), Peter G. Schultz(Scripps Research Institute), Damien Bresson(Ambrx (United States)), Maribel Beaumont(Merck & Co., Inc., Rahway, NJ, USA (United States)), Guo Feng, Linda Liang(Merck & Co., Inc., Rahway, NJ, USA (United States)), SuChun Hsieh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ying Sun(Wuhan University), Dennis Gately(Ambrx (United States)), Philip E. Brandish, Sanjiv Shah, Deborah Dooney
Journal of the American Chemical Society
January 9, 2016
Cited by 141


Related Papers